Literature DB >> 12745458

Immunohistochemical characterisation of pulmonary hyaline membrane in various types of interstitial pneumonia.

A-Ping Sun1, Yuji Ohtsuki, Jiro Fujita, Toshihiko Ishida, Takeo Yoshinouchi, Nobuoki Kohno.   

Abstract

AIMS: Hyaline membrane (HM) in diffuse alveolar damage (DAD) pattern is frequently detected in the acute stage of interstitial pneumonia (IP). To determine the exact nature of HM, we investigated immunohistochemically 25 cases of HM-containing IP.
METHODS: The cases examined using various kinds of antibodies were four cases associated with rheumatoid arthritis, five with usual interstitial pneumonia, two with dermatomyositis, five with viral infection, one case with progressive systemic sclerosis and eight cases caused by other agents.
RESULTS: HM mostly reacted with antibodies to PE10 (SP-A), Factor VIII, KL-6 and EMA and, interestingly, stained for AE1/AE3, CK19, and Hup-1 in some cases, but was negative for PTAH staining. However, the immunoreactivities of HM varied even within the same disease or section.
CONCLUSIONS: The immunohistochemical heterogeneity of HM suggests that HM may be formed by different mechanisms in various types of IP. Our findings also suggest that the main components of HM are derived from alveolar epithelial cells and their proteins, some including cytoplasmic element of CK19, and also from serum factors, but not fibrin. The immunohistochemical characteristics of HM in DAD pattern will aid understanding of the significance of HM formation in IP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745458

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias.

Authors:  Yuji Ohtsuki; Norihiko Nakanishi; Jiro Fujita; Takeo Yoshinouchi; Makoto Kobayashi; Nobuo Ueda; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

2.  Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders.

Authors:  Riitta Kaarteenaho; Vuokko L Kinnula
Journal:  Pulm Med       Date:  2010-11-02

3.  Converting everolimus to mycophenolate mofetil ameliorated prolonged respiratory syncytial virus infection in a child after heart transplantation.

Authors:  Hidehiro Suginobe; Nobutoshi Nawa; Hidekazu Ishida; Shigetoyo Kogaki
Journal:  BMJ Case Rep       Date:  2017-08-03

4.  LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.

Authors:  Yasunori Enomoto; Sayomi Matsushima; Kiyoshi Shibata; Yoichiro Aoshima; Haruna Yagi; Shiori Meguro; Hideya Kawasaki; Isao Kosugi; Tomoyuki Fujisawa; Noriyuki Enomoto; Naoki Inui; Yutaro Nakamura; Takafumi Suda; Toshihide Iwashita
Journal:  Clin Sci (Lond)       Date:  2018-07-31       Impact factor: 6.124

5.  Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore.

Authors:  Teri J Franks; Pek Y Chong; Paul Chui; Jeffrey R Galvin; Raina M Lourens; Ann H Reid; Elena Selbs; Col Peter L McEvoy; Col Dennis L Hayden; Junya Fukuoka; Jeffery K Taubenberger; William D Travis
Journal:  Hum Pathol       Date:  2003-08       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.